Masimo MASI announced that the FDA has granted De Novo status to its noninvasive, continuous parameter — ORi (Oxygen Reserve Index) — designed to provide additional insight into a patient's oxygen ...
(MENAFN- AETOSWire) (BUSINESS WIRE ) -- Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Anesthesia in which Dr. Yu Jeong Bang and colleagues at ...
In the Largest Study of ORi to Date, of 554 Patients, Researchers Conclude: "ORi Can Provide Useful Information on Arterial Oxygenation Even During One-Lung Ventilation" Masimo (NASDAQ: MASI) today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results